Cited by 22Escherichia coli research studiesCancer Research and TreatmentsBacterial Genetics and Biotechnology

Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli

Open access
Mäklin, Tommi, Taira, Aurora, Arredondo-Alonso, Sergio, Shao, Yan, Stratton, Michael R, Lawley, Trevor D, Aaltonen, Lauri A, Corander, Jukka·2025·The Lancet Microbe

Abstract

Biomedical research has implicated the bacterial metabolite colibactin as a causal risk factor for several cancer types, in particular, colorectal cancer. Colibactin has been known to drive tumorigenesis by inducing double-strand breaks in the DNA of epithelial cells exposed to colibactin-producing bacteria. Some phylogroup B2 Escherichia coli secrete colibactin during interbacterial warfare, concomitantly exposing the host to an increasing risk of DNA damage. This Personal View reviews the current knowledge about the cancer-colibactin interface and summarises metagenomics-based and population-genomics-based surveys to show that the prevalence of dominant colibactin-producing lineages of E coli varies considerably across geographical regions. The prevalence is further strongly associated with the age-standardised incidences of colorectal cancer, bladder cancer, and prostate cancer, suggesting that the degree of colibactin exposure in a population might contribute to the geographical variation of these cancers. Our observations provide a strong impetus for further research and the development of novel interventions to reduce the risks for colibactin-related cancers.

Integrity signals

Registry

Crossref · 10.1016/j.lanmic.2024.101015

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mäklin, T., Taira, A., Arredondo-Alonso, S., Shao, Y., Stratton, M. R., Lawley, T. D., Aaltonen, L. A., & Corander, J.
Affiliations
  • University of Helsinki (FI)
  • University of Oslo (NO)
  • Wellcome Sanger Institute (GB)
Corresponding author
Corander, Jukka
Venue
The Lancet Microbe
Publisher
Elsevier BV
Published
2025-05
Volume
6
Issue
5
Pages
101015
ISSN
2666-5247 (ISSN-L)
OpenAlex
W4405008105
Cited by
22
References
42
Citations by year
2026: 13 · 2025: 9
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • The Lancet Microbe (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Research Council of Finland (352814, 319083, 320149)
  • Syöpäsäätiö (66-6746)
  • Wellcome Trust (220540/Z/20/A)
  • Research Council of Norway (299941)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Escherichia coli research studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
colibactin, colorectal cancer, bladder cancer, prostate cancer, urinary tract cancer, geographical variation in cancer incidence, phylogroup B2, DNA double-strand breaks, carcinogenesis, bacterial metabolites, population genomics, metagenomics, cancer risk factors
MeSH terms
Urinary Bladder Neoplasms, Escherichia coli, Escherichia coli Infections, Humans, Male, Peptides, Prostatic Neoplasms, Colorectal Neoplasms, Incidence, Polyketides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review